Human intestinal epithelium in a dish: Current models for research into gastrointestinal pathophysiology

United European Gastroenterology Journal

Volumn 5, Issue 8, 2017, Pages 1073-1081

  Noben, Manuel ^a,b   Vanhove, Wiebe ^a   Arnauts, Kaline ^a,b   Santo Ramalho, Anabela ^b   Van Assche, Gert ^a,c   Vermeire, Séverine ^a,c   Verfaillie, Catherine ^b   Ferrante, Marc ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

2D cultures; epithelial models; Organoids

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; COLLAGEN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GLUCOSE TRANSPORTER 5; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; MATRIGEL; MATRILYSIN; MICRORNA; POTASSIUM PROTON EXCHANGE PROTEIN; PROTEIN P53; SMAD4 PROTEIN; SODIUM GLUCOSE COTRANSPORTER 1; TUMOR NECROSIS FACTOR;

ANTIGEN PRESENTING CELL; CANCER INHIBITION; CELL CULTURE; CELL PROLIFERATION; CRISPR-CAS9 SYSTEM; CYSTIC FIBROSIS; DISEASE MODEL; ENDOPLASMIC RETICULUM STRESS; EXPLANT; GASTROINTESTINAL DISEASE; GENE MUTATION; GENETIC STABILITY; HELICOBACTER PYLORI; HIGH THROUGHPUT SCREENING; HOMEOSTASIS; HUMAN; IMMORTALIZED CELL LINE; INFLAMMATORY BOWEL DISEASE; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; MONOLAYER CULTURE; NECROTIZING ENTEROCOLITIS; NONHUMAN; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SALMONELLA ENTERICA; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; ULCERATIVE COLITIS; WESTERN BLOTTING;

EID: 85037036258     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640617722903     Document Type: Review

References (58)

1. Ahmad R, Sorrell MF, Batra SK, Gut permeability and mucosal inflammation: Bad, good or context dependent. Mucosal Immunol 2017; 10: 307–317.
2. Hay M, Thomas DW, Craighead JL, Clinical development success rates for investigational drugs. Nat Biotechnol 2014; 32: 40–51.
3. Liévin-Le Moal V, Servin AL. Pathogenesis of human enterovirulent bacteria: Lessons from cultured, fully differentiated human colon cancer cell lines. Microbiol Mol Biol Rev 2013; 77: 380–439.
4. Varadi J, Harazin A, Fenyvesi F, Alpha-melanocyte stimulating hormone protects against cytokine-induced barrier damage in Caco-2 intestinal epithelial monolayers. PLoS One 2017; 12: e0170537–e0170537.
5. Spinks CB, Zidan AS, Khan MA, Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: In vitro pharmaceutics and Caco-2 permeability investigations. Clin Pharmacol 2017; 9: 29–38.
6. Walter E, Janich S, Roessler BJ, HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: In vitro-in vivo correlation with permeability data from rats and humans. J Pharm Sci 1996; 85: 1070–1076.
7. Chen Y, Lin Y, Davis KM, Robust bioengineered 3D functional human intestinal epithelium. Sci Rep 2015; 5: 13708–13708.
8. Kim HJ, Li H, Collins JJ, Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc Natl Acad Sci U S A 2016; 113: E7–E15.
9. Lozoya-Agullo I, Araújo F, González-Álvarez I, Usefulness of Caco-2/HT29-MTX and Caco-2/HT29-MTX/Raji B coculture models to predict intestinal and colonic permeability compared to Caco-2 monoculture. Mol Pharm 2017; 14: 1264–1270.
10. Kusek ME, Pazos MA, Pirzai W, In vitro coculture assay to assess pathogen induced neutrophil trans-epithelial migration. J Vis Exp 2014, pp. 83: e50823–83: e50823.
11. Perreault N, Beaulieu JF. Primary cultures of fully differentiated and pure human intestinal epithelial cells. Exp Cell Res 1998; 245: 34–42.
12. Scott A, Rouch JD, Jabaji Z, Long-term renewable human intestinal epithelial stem cells as monolayers: A potential for clinical use. J Pediatr Surg 2016; 51: 995–1000.
13. Graves CL, Harden SW, LaPato M, A method for high purity intestinal epithelial cell culture from adult human and murine tissues for the investigation of innate immune function. J Immunol Methods 2014; 414: 20–31.
14. Pedersen G, Saermark T, Giese B, A simple method to establish short-term cultures of normal human colonic epithelial cells from endoscopic biopsy specimens. Comparison of isolation methods, assessment of viability and metabolic activity. Scand J Gastroenterol 2000; 35: 772–780.
15. Vanhove W, Nys K, Arijs I, P095 The genetic risk in ER stress and autophagy translates into quantifiable epithelial ER stress levels in IBD patients. J Crohns Colitis 2017; 11: s124–s125.
16. Barker N, van Es JH, Kuipers J, Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007; 449: 1003–1007.
17. Sato T, Stange DE, Ferrante M, Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology 2011; 141: 1762–1772.
18. Sato T, Vries RG, Snippert HJ, Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009; 459: 262–265.
19. van de Wetering M, Francies HE, Francis JM, Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 2015; 161: 933–945.
20. Spence JR, Mayhew CN, Rankin SA, Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 2011; 470: 105–109.
21. Finkbeiner SR, Hill DR, Altheim CH, Transcriptome-wide analysis reveals hallmarks of human intestine development and maturation in vitro and in vivo. Stem Cell Reports 2015; 4: 1140–1155.
22. Nozaki K, Mochizuki W, Matsumoto Y, Co-culture with intestinal epithelial organoids allows efficient expansion and motility analysis of intraepithelial lymphocytes. J Gastroenterol 2016; 51: 206–213.
23. Workman MJ, Mahe MM, Trisno S, Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system. Nat Med 2017; 23: 49–59.
24. Zietek T, Rath E, Haller D, Intestinal organoids for assessing nutrient transport, sensing and incretin secretion. Sci Rep 2015; 5: 16831–16831.
25. Foulke-Abel J, In J, Yin J, Human enteroids as a model of upper small intestinal ion transport physiology and pathophysiology. Gastroenterology 2016; 150: 638–649.e8.
26. Jattan J, Rodia C, Li D, Using primary murine intestinal enteroids to study dietary TAG absorption, lipoprotein synthesis, and the role of apoC-III in the intestine. J Lipid Res 2017; 58: 853–865.
27. Dekkers JF, Wiegerinck CL, de Jonge HR, A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nat Med 2013; 19: 939–945.
28. Schwank G, Koo BK, Sasselli V, Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 2013; 13: 653–658.
29. Mora-Buch R, Dotti I, Planell N, Epithelial IL-1R2 acts as a homeostatic regulator during remission of ulcerative colitis. Mucosal Immunol 2016; 9: 950–959.
30. Dotti I, Mora-Buch R, Ferrer-Picón E, et al. Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis. Gut. Epub ahead of print 1 November 2016. DOI: 10.1136/gutjnl-2016-312609
31. Noben M, Verstockt B, de Bruyn M, et al. Epithelial organoid cultures from patients with ulcerative colitis and Crohn’s disease: A truly long-term model to study the molecular basis for inflammatory bowel disease? Gut. Epub ahead of print 3 February 2017. DOI: 10.1136/gutjnl-2016-313667
32. Neal MD, Sodhi CP, Jia H, Toll-like receptor 4 is expressed on intestinal stem cells and regulates their proliferation and apoptosis via the p53 up-regulated modulator of apoptosis. J Biol Chem 2012; 287: 37296–37308.
33. Wiegerinck CL, Janecke AR, Schneeberger K, Loss of syntaxin 3 causes variant microvillus inclusion disease. Gastroenterology 2014; 147: 65–68.e10.
34. Drost J, van Jaarsveld RH, Ponsioen B, et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature 2015; 521: 43–47
35. Matano M, Date S, Shimokawa M, Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids. Nat Med 2015; 21: 256–262.
36. Rouch JD, Scott A, Lei NY, Development of functional microfold (M) cells from intestinal stem cells in primary human enteroids. PLoS One 2016; 11: e0148216–e0148216.
37. Wilson SS, Tocchi A, Holly MK, A small intestinal organoid model of non-invasive enteric pathogen-epithelial cell interactions. Mucosal Immunol 2015; 8: 352–361.
38. Finkbeiner SR, Zeng XL, Utama B, Stem cell-derived human intestinal organoids as an infection model for rotaviruses. MBio 2012; 3: e00159–e12.
39. Yin Y, Bijvelds M, Dang W, Modeling rotavirus infection and antiviral therapy using primary intestinal organoids. Antiviral Res 2015; 123: 120–131.
40. Bartfeld S, Bayram T, van de Wetering M, In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection. Gastroenterology 2015; 148: 126–136.e6.
41. Browne HP, Forster SC, Anonye BO, Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation. Nature 2016; 533: 543–546.
42. Peck BC, Mah AT, Pitman WA, Functional transcriptomics in diverse intestinal epithelial cell types reveals robust microRNA sensitivity in intestinal stem cells to microbial status. J Biol Chem 2017; 292: 2586–2600.
43. Hibiya S, Tsuchiya K, Hayashi R, Long-term inflammation transforms intestinal epithelial cells of colonic organoids. J Crohns Colitis 2017; 11: 621–630.
44. Huch M, Gehart H, van Boxtel R, Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 2015; 160: 299–312.
45. Huch M, Bonfanti P, Boj SF, Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis. EMBO J 2013; 32: 2708–2721.
46. Fukuda M, Mizutani T, Mochizuki W, Small intestinal stem cell identity is maintained with functional Paneth cells in heterotopically grafted epithelium onto the colon. Genes Dev 2014; 28: 1752–1757.
47. Middendorp S, Schneeberger K, Wiegerinck CL, Adult stem cells in the small intestine are intrinsically programmed with their location-specific function. Stem Cells 2014; 32: 1083–1091.
48. Fordham RP, Yui S, Hannan NR, Transplantation of expanded fetal intestinal progenitors contributes to colon regeneration after injury. Cell Stem Cell 2013; 13: 734–744.
49. Jarry A, Malard F, Bou-Hanna C, Interferon-alpha promotes Th1 response and epithelial apoptosis via inflammasome activation in human intestinal mucosa. Cell Mol Gastroenterol Hepatol 2017; 3: 72–81.
50. Herrmann JR, Turner JR. Beyond Ussing’s chambers: Contemporary thoughts on integration of transepithelial transport. Am J Physiol Cell Physiol 2016; 310: C423–C431.
51. Ussing HH. Transport through biological membranes. Annu Rev Physiol 1953; 15: 1–20.
52. Tsilingiri K, Barbosa T, Penna G, Probiotic and postbiotic activity in health and disease: Comparison on a novel polarised ex-vivo organ culture model. Gut 2012; 61: 1007–1015.
53. Yissachar N, Zhou Y, Ung L, An intestinal organ culture system uncovers a role for the nervous system in microbe-immune crosstalk. Cell 2017; 168: 1135–1148.e12.
54. Ettayebi K, Crawford SE, Murakami K, Replication of human noroviruses in stem cell-derived human enteroids. Science 2016; 353: 1387–1393.
55. VanDussen KL, Marinshaw JM, Shaikh N, Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut 2015; 64: 911–920.
56. Levy M, Kolodziejczyk AA, Thaiss CA, Dysbiosis and the immune system. Nat Rev Immunol 2017; 17: 219–232.
57. van den Elsen LW, Poyntz HC, Weyrich LS, Embracing the gut microbiota: The new frontier for inflammatory and infectious diseases. Clin Transl Immunology 2017; 6: e125–e125.
58. Tsilimigras MC, Fodor A, Jobin C. Carcinogenesis and therapeutics: The microbiota perspective. Nat Microbiol 2017; 2: 17008–17008.